跳到正文
原文
Nature Biotechnology· Michael Eisenstein·· 2026-10-19AI 评分35

Nature Biotechnology 年度评选:Bioptimus 及其 AI 病理模型

Editor’s pick: Bioptimus

AI 导读

Bioptimus 入选 Nature Biotechnology 年度早期大额融资企业名单。该公司正开发多模态、多尺度 AI 病理模型,用于生物标志物预测及药物治疗预测。

正文

Nature Biotechnology, Published online: 19 October 2026; doi:10.1038/s41587-026-03345-4

Each year, Nature Biotechnology highlights companies that received sizeable early-stage funding in the previous year. Bioptimus is developing multimodal and multiscale AI pathology models for biomarker and drug treatment prediction.

来源:Nature Biotechnology · nature.com